z-logo
Premium
Affinity probe capillary electrophoresis of insulin using a fluorescence‐labeled recombinant Fab as an affinity probe
Author(s) -
Shimura Kiyohito,
Kasai KenIchi
Publication year - 2014
Publication title -
electrophoresis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.666
H-Index - 158
eISSN - 1522-2683
pISSN - 0173-0835
DOI - 10.1002/elps.201300464
Subject(s) - capillary electrophoresis , chemistry , fluorescence , rhodamine b , chromatography , rhodamine , capillary action , electrophoresis , analytical chemistry (journal) , biochemistry , materials science , physics , quantum mechanics , photocatalysis , composite material , catalysis
Affinity probe CE (APCE) separates and detects a target molecule as a complex using a fluorescence‐labeled affinity probe (AP) by CE. The electrophoretic separation of the complex ensures accurate identification of a specific signal among nonspecific ones, which often compromises the credibility of immunoassays. APCE of insulin using a recombinant Fab (rFab) as an AP was demonstrated as a model system in this report. Anti‐insulin rFab was expressed in Escherichia coli and labeled at a cysteine residue in the hinge region with a thiol‐reactive rhodamine dye. Electrophoretically pure labeled rFab was recovered from a focused band in slab‐gel IEF and used as an AP. A mixture of standard insulin and the AP with carrier ampholyte was introduced into a neutral‐polymer coated fused silica capillary (50 μm id, 120 mm long). IEF was carried out at 500 V/cm, and the capillary was scanned for laser‐induced fluorescence under focusing conditions. The insulin‐AP complex focused at pH 6.6 within 6 min along with the free AP at pH 7.6. The complex peak decayed according to the first‐order reaction kinetics with a half life of 3.8 min. A linear calibration line was obtained for standard insulin at a concentration range of 20 pM to 5 nM using the AP at 50 nM. These results demonstrate that rFab is useful for the preparation of an AP for APCE.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here